Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients

NCT07840599 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT07840599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07840599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
June 15, 2031
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, metastatic breast cancer (mbc), metastatic breastcancer